Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.
Singh N, Eickhoff C, Garcia-Agundez A, Bertone P, Paudel SS, Tambe DT, Litzky LA, Cox-Flaherty K, Klinger JR, Monaghan SF, Mullin CJ, Pereira M, Walsh T, Whittenhall M, Stevens T, Harrington EO, Ventetuolo CE. Singh N, et al. Among authors: klinger jr. Sci Rep. 2023 Dec 18;13(1):22534. doi: 10.1038/s41598-023-48077-6. Sci Rep. 2023. PMID: 38110438 Free PMC article.
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.
Walters R, Vasilaki E, Aman J, Chen CN, Wu Y, Liang OD, Ashek A, Dubois O, Zhao L, Sabrin F, Cebola I, Ferrer J, Morrell NW, Klinger JR, Wilkins MR, Zhao L, Rhodes CJ. Walters R, et al. Among authors: klinger jr. Circulation. 2023 May 23;147(21):1606-1621. doi: 10.1161/CIRCULATIONAHA.122.061940. Epub 2023 Apr 17. Circulation. 2023. PMID: 37066790 Free PMC article.
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry.
DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ; PHAR Investigators. DuBrock HM, et al. Among authors: klinger jr. Pulm Circ. 2022 Dec 15;12(4):e12172. doi: 10.1002/pul2.12172. eCollection 2022 Oct. Pulm Circ. 2022. PMID: 36540874 Free PMC article.
Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension.
Sun X, Nakajima E, Norbrun C, Sorkhdini P, Yang AX, Yang D, Ventetuolo CE, Braza J, Vang A, Aliotta J, Banerjee D, Pereira M, Baird G, Lu Q, Harrington EO, Rounds S, Lee CG, Yao H, Choudhary G, Klinger JR, Zhou Y. Sun X, et al. Among authors: klinger jr. JCI Insight. 2022 Sep 22;7(18):e159578. doi: 10.1172/jci.insight.159578. JCI Insight. 2022. PMID: 35951428 Free PMC article.
Natriuretic peptide receptor-C mediates the inhibitory effect of atrial natriuretic peptide on neutrophil recruitment to the lung during acute lung injury.
Harrington EO, Kumar A, Leandre V, Wilson ZS, Guarino B, Braza J, Lefort CT, Klinger JR. Harrington EO, et al. Among authors: klinger jr. Am J Physiol Lung Cell Mol Physiol. 2022 Oct 1;323(4):L438-L449. doi: 10.1152/ajplung.00477.2021. Epub 2022 Aug 9. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35943160 Free PMC article.
Reply to Helgeson et al.: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
LaPatra T, Baird GL, Goodman R, Pinder D, Gaffney M, Klinger JR, Palevsky HI, Fritz J, Mullin CJ, Mazurek JA, Kawut SM, Ventetuolo CE. LaPatra T, et al. Among authors: klinger jr. Am J Respir Crit Care Med. 2022 Sep 1;206(5):651-653. doi: 10.1164/rccm.202205-0867LE. Am J Respir Crit Care Med. 2022. PMID: 35608538 Free PMC article. No abstract available.
137 results